Details for New Drug Application (NDA): 203503
✉ Email this page to a colleague
The generic ingredient in VORICONAZOLE is voriconazole. There are fourteen drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the voriconazole profile page.
Summary for 203503
Tradename: | VORICONAZOLE |
Applicant: | Glenmark Pharms Ltd |
Ingredient: | voriconazole |
Patents: | 0 |
Suppliers and Packaging for NDA: 203503
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
VORICONAZOLE | voriconazole | TABLET;ORAL | 203503 | ANDA | American Health Packaging | 60687-273 | 60687-273-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-273-21) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-273-11) |
VORICONAZOLE | voriconazole | TABLET;ORAL | 203503 | ANDA | American Health Packaging | 60687-294 | 60687-294-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-294-21) / 1 TABLET, FILM COATED in 1 BLISTER PACK (60687-294-11) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Sep 2, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 200MG | ||||
Approval Date: | Sep 2, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription